Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
Susceptibilities of trimethoprim and sulfamethoxazole were tested alone and in combination (1:20) against 94 isolants of obligate anaerobes from clinical specimens. Ninety percent of the isolants were inhibited by less than 0.25 microgram - less than 4.75 micrograms trimethoprim-sulfamethoxazole/ml; 5.4 micrograms trimethoprim/ml and; 900 micrograms sulfamethoxazole/ml. We concluded that trimethoprim-sulfamethoxazole would be effective in the treatment of infectious processes containing species of obligate anaerobes, including those resistant to the penicillin and cephalothin groups of antibiotics.
D004338:Drug Combinations / Q000494:pharmacology; D006089:Gram-Negative Anaerobic Bacteria / Q000187:drug effects*; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D013420:Sulfamethoxazole / Q000494:pharmacology*; D014295:Trimethoprim / Q000494:pharmacology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole